Sabby Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Sabby Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-169,000	Closed	-$987K	–	417
2015 Q3	$987K	Buy	169,000 +3,730	+2%	+$28.7K	0.04%	236
2015 Q2	$1.37M	Sell	165,270 -8,482	-5%	-$75K	0.05%	202
2015 Q1	$1.43M	Buy	173,752 +109,864	+172%	+$812K	0.06%	166
2014 Q4	$439	Sell	63,888 -138,557	-68%	-$867K	0.01%	192
2014 Q3	$1.09K	Buy	202,445 +75,561	+60%	+$441K	0.04%	151
2014 Q2	$808K	Buy	+126,884	New	+$873K	0.03%	166
2013 Q4	–	Sell	-31,553	Closed	-$170K	–	260
2013 Q3	$581K	Buy	+31,553	New	+$613K	0.04%	149

Other funds holding ARIA

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Sabby Management's ARIA Position: Q4 2015 in Review

Sabby Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2015, closing a stake of 169,000 shares — an estimated $987K sold.

Sabby Management first reported a position in ARIA in Q3 2013 and held it in 7 quarters. The position peaked at $1.43M in Q1 2015. 172 funds tracked by Wall St. Rank hold ARIA as of Q4 2015.

Sabby Management reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
Sabby Management sold 169,000 Ariad Pharmaceuticals Inc shares in Q4 2015, an estimated $987K.
Sabby Management first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 7 quarters.
Sabby Management's Ariad Pharmaceuticals Inc position peaked at $1.43M in Q1 2015.
172 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2015.

Based on Sabby Management's 13F filing for Q4 2015, filed 16 Feb 2016.